2
Clinical Trials associated with Group A and C meningococcal polysaccharide vaccine(Wuhan Institute of Biological Products)评价AC群脑膜炎球菌多糖疫苗的安全性及免疫原性的单中心、随机、盲法、同类疫苗对照的III期临床试验
[Translation] A single-center, randomized, blinded, similar vaccine-controlled phase III clinical trial to evaluate the safety and immunogenicity of group AC meningococcal polysaccharide vaccine
评价A+C群脑膜炎球菌多糖疫苗在2岁及以上健康人群中接种的安全性和接种A+C群脑膜炎球菌多糖疫苗后的抗体阳转率。
[Translation] To evaluate the safety of group A+C meningococcal polysaccharide vaccine in healthy people aged 2 years and above and the antibody seroconversion rate after vaccination with group A+C meningococcal polysaccharide vaccine.
评价AC群脑膜炎球菌多糖疫苗的安全性的单臂I期临床试验
[Translation] A single-arm phase I clinical trial to evaluate the safety of group AC meningococcal polysaccharide vaccine
评价A+C群脑膜炎球菌多糖疫苗在2岁及以上健康人群中接种的安全性。
[Translation] To evaluate the safety of group A+C meningococcal polysaccharide vaccine in healthy people aged 2 years and above.
100 Clinical Results associated with Group A and C meningococcal polysaccharide vaccine(Wuhan Institute of Biological Products)
100 Translational Medicine associated with Group A and C meningococcal polysaccharide vaccine(Wuhan Institute of Biological Products)
100 Patents (Medical) associated with Group A and C meningococcal polysaccharide vaccine(Wuhan Institute of Biological Products)
100 Deals associated with Group A and C meningococcal polysaccharide vaccine(Wuhan Institute of Biological Products)